Cephalon Defends Narcolepsy Drug From Generics At Trial
Cephalon Inc. squared off with a host of generic-drug makers in Delaware federal court on Wednesday in a patent infringement suit aiming to block generic versions of its narcolepsy drug Nuvigil...To view the full article, register now.
Already a subscriber? Click here to view full article